Search results
Monica A. Kolinsky, Ph.D.
The National Law Review· 11 hours agoMonica is an Associate in the Corporate Department and a member of the Life Sciences Practice Group, and is based in the firm’s Stamford office. Before joining the firm, Monica was of counsel ...
Nautilus Biotechnology Inc (NAUT) Q1 2024 Earnings Call Transcript Highlights: A Detailed ...
GuruFocus.com via Yahoo Finance· 1 day agoExplore key financial outcomes and strategic insights from Nautilus Biotechnology's first quarter of 2024, emphasizing growth in expenses and future expectations.
Moderna (MRNA) Reports Q1 Loss, Tops Revenue Estimates
Zacks· 13 hours agoFree Report) came out with a quarterly loss of $3.07 per share versus the Zacks Consensus Estimate of a loss of $3.59. This quarterly report represents an earnings surprise of 14.48%. A quarter ...
Novartis to pay up to $1.75 billion for U.S. cancer-focused biotech
Market Watch· 7 hours agoNovartis said it’s paying $1 billion upfront and up to $750 million more in milestone payments for...
CB Therapeutics Unveils Revolutionary Breakthroughs in Crafting Pharmaceutical-Grade Cannabinoids...
Digital Journal· 4 hours agoPRESS RELEASE Published May 2, 2024 Newsfile Carlsbad, California--(Newsfile Corp. - May 2, 2024) - CB Therapeutics , a leading biotechnology firm specializing in precision ...
Regeneron Pharmaceuticals 1Q Revenue Declines Amid Lower EYLEA Sales
Market Watch· 7 hours agoBy Denny Jacob Regeneron Pharmaceuticals posted lower-than-expected revenue in its latest quarter which resulted in part from lower sales of EYLEA in the...
The Volatility of Sana Biotechnology Inc’s (SANA) Stock: A 11.25% Ratio for the Week – News Heater
NewsHeater· 2 days agoThe stock of Sana Biotechnology Inc (SANA) has gone up by 11.25% for the week, with a -11.07% drop in the past month and a 59.29% rise in the past quarter. The volatility ...
Gordian Biotechnology Introduces High-Throughput In Vivo Screening Platform to Discover Therapies...
The Record Gazette· 6 days agoTraditional Drug Discovery Compared to Gordian Biotechnology
Gordian Biotechnology Introduces High-Throughput In Vivo Screening Platform to Discover Therapies...
FOX 4 Kansas City· 6 days agoGordian Biotechnology, an in vivo drug discovery and development company, today announced its...
Evogene (NASDAQ:EVGN) Now Covered by Analysts at StockNews.com
ETF DAILY NEWS· 16 hours agoStockNews.com began coverage on shares of Evogene (NASDAQ:EVGN – Get Free Report) in a report issued on Thursday. The firm set a “sell” rating on the biotechnology company ...
